Although the FDA updated Abilify’s labels to include warnings for compulsive actions in 2016, the damage had previously been done to countless consumers with the drug. Consequently, sufferers started submitting lawsuits versus Otsuka and Bristol-Myers Squibb. Plaintiffs declare that the two firms realized or should have known that Abilify ca